Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
45 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Arthritis, Juvenile Rheumatoid"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention:
2 Not yet recruiting Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Blood sample
3 Unknown  Juvenile Rheumatoid Arthritis Research Registry
Condition: Juvenile Rheumatoid Arthritis
Intervention:
4 Unknown  Cost of Care for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
5 Not yet recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
6 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
7 Recruiting Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Genetic: Blood test
8 Unknown  Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
9 Recruiting An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
10 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
11 Unknown  The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Uveitis;   Arthritis, Juvenile Rheumatoid
Intervention: Drug: TNFR:Fc
12 Recruiting Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis;   Temporomandibular Arthritis
Intervention:
13 Unknown  Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: comparison of types of sleep disordered breathing
14 Not yet recruiting Biomarkers in Idiopathic Juvenile Arthritis
Condition: Idiopathic Juvenile Arthritis
Intervention: Other: blood sample for identifying biomarkers
15 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
16 Recruiting Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Leflunomide
17 Unknown  Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: etanercept
18 Recruiting Long-Term Safety Study Of CP-690,550 In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
19 Recruiting Virtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: Virtual Peer-to-Peer Support Mentoring
20 Recruiting Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years